ETFMG Alternative Harvest ETF

Today, OrganiGram Holdings (NASDAQ:OGI) reported its third-quarter earnings. As expected, the results were disappointing.

OrganiGram will likely report its third-quarter earnings before the market opens on July 21. Overall, there isn’t much hope.

Aphria (NYSE:APHA) received a bullish call from Stifel. On Monday, Stifel upgraded the stock from a “hold” to a “buy” rating.

Analysts expect Aphria to report revenues of $631.8 million in the next four quarters. Management will focus on the medical and recreational sectors.

Today, HEXO announced that it launched its medical marijuana products in Israel. The company signed a two-year agreement with an Israeli cannabis company.

Curaleaf Holdings (OTCMKTS:CURLF) continued its expansion by completing the acquisition of Curaleaf NJ, which owns a medical license in New Jersey.

As the demand for Cannabis 2.0 products continues to rise, Aurora Cannabis announced the appointment of Miguel Martin as its new chief commercial officer.

Curaleaf (OTCMKTS:CURLF) acquired a “Select” brand in February 2020. The company received positive feedback in medical and adult-use markets.

On Monday, Cantech Letter reported that Raymond James downgraded OrganiGram from an “outperform” rating to a “market perform” rating.

On June 27, Green Thumb Industries (OTCMKTS:GTBIF) opened its fifth Essence brand store in Las Vegas and its 48th retail store in the US.

In the fourth quarter, Canopy Growth (NYSE:CGC)(TSE:WEED) lost market share due to increased competition in value products.

In April, cannabis sales came in at $180.1 million—0.6% down from the March sales. So, considering the spike in March, the sales weren’t disappointing.

The Virginia Board of Pharmacy voted not to extend MedMen’s conditional license to operate a medical marijuana dispensary in Staunton, Virginia.

Tilray hasn’t reported a positive EBITDA yet. Analysts expect the company to become profitable in the first quarter of 2021.

Amid the growing support for cannabis legalization, Canopy Growth (NYSE:CGC) CEO David Klein expects the federal government to legalize marijuana by 2022.

After underperforming the broader equity markets in the first quarter, the cannabis sector has been showing a strong recovery in the second quarter.

On Monday, Curaleaf Holdings announced that it will expand its Select brand products in Connecticut. The products will be available at medical dispensaries.

Canada, with first-mover advantage, has been exploring new territories to export its cannabis oil. Last year, the company reported to 17 counties.

Innovative Industrial Properties has continued its aggressive expansion. IIPR acquired a new property in Pennsylvania from Holistic Industries.

Illinois sold recreational cannabis worth $44.3 million in May—the highest amount since it legalized recreational sales in January this year.

On Monday, Vireo Health announced that it terminated Bruce Linton as its executive chairman immediately. He joined the company in November 2019.

The budget proposed by Governor Gavin Newsom projected a decline in California’s cannabis sales. COVID-19 induced a recession in the US economy.

On May 26, Tilray (NASDAQ:TLRY) announced that it will permanently shut down its High Park Gardens facility located in Leamington, Ontario.

Canadian cannabis companies are frustrated by the Jamaican government’s inaction. They have decided to cut their losses and exit the Jamaican market.

OrganiGram (NASDAQ:OGI) had good news for patients who use cannabis for medical purposes. The company expanded its medical cannabis offerings.

Despite the surge in May, Canopy Growth is still trading at a 54.3% discount from its 52-week high of $59.74. So, should you buy the stock?

Earlier this week, Curaleaf (OTCMKTS:CURLF) reported its first-quarter earnings. The company missed analysts’ revenue expectations.

On Wednesday, Aurora Cannabis (NYSE:ACB) announced that it has signed an agreement to acquire Reliva—a US-based CBD company.

On Monday, Curaleaf (OTCMKTS:CURLF) reported its first-quarter earnings after the market closed. The company reported revenue of $96.5 million.

Analysts expect Curaleaf’s EBITDA to rise during the quarter. They expect the company to report an EBITDA of $15.7 million.

Today, Charlotte’s Web reported a mixed first-quarter performance. For the quarter ended on March 31, the company reported revenues of $21.7 million.

On Monday, GW Pharmaceuticals reported its first-quarter earnings. The company beat analysts’ revenue, EBITDA, and EPS expectations.

On Monday, Tilray (NASDAQ:TLRY) reported its first-quarter earnings after the market closed. For the quarter, the company posted revenues of $52.1 million.

On May 8, Aphria’s (NYSE:APHA) management announced that it agreed to repurchase its convertible senior notes from some holders outside of Canada.

Charlotte’s Web Holdings (OTCMKTS:CWBHF)(NYSEARCA:CWEB) will likely report its first-quarter earnings before the market opens on May 14.

The meltdown in global financial markets amid COVID-19 dragged Tilray stock down to $2.43 on March 18. Since then, the stock has recovered.

On May 6, Innovative Industrial Properties reported its first-quarter results after the market closed. The company posted an adjusted EPS of $0.72.

Today, Aphria (NYSE:APHA) announced that ASG Pharma has received EU GMP certification to produce cannabis for medical and research purposes.

Aphria reported an adjusted EBITDA of $5.7 million in the third quarter. The company has reported a positive EBITDA for four consecutive quarters.

IIPR will likely report its first-quarter earnings, which ended on March 31, after the market closes on May 6. So, should you buy the stock?

Analysts expect Cresco Labs to report revenue of $43.7 million in the fourth quarter—YoY growth of 157.9% from $17.0 million in the fourth quarter of 2018.

Canopy Growth (NYSE:CGC)(TSE:WEED) stock rose to a high of 22.66 Canadian dollars before closing at 21.46 Canadian dollars on Monday.

Canopy Growth announced another set of global operational changes to optimize its production, improve efficiency, and align its supply with the demand.

On April 14, Aphria (NYSE:APHA) reported its third-quarter earnings. For the quarter, the company reported revenues of 144.4 million Canadian dollars.

Canopy Growth and Aurora Cannabis are two prominent players in the cannabis sector. So far in 2020, Canopy Growth has outperformed cannabis ETFs.

Analysts expect Aphria to report revenue of 130.6 million Canadian dollars in the third quarter—growth of 77.5% YoY and a sequential increase of 8.3%.

OrganiGram has joined the list of cannabis companies, like Canopy Growth and Aurora Cannabis, that will reduce their workforce.

On April 6, Bruce Linton said that Canopy Growth (TSE:WEED) and Cronos Group (NASDAQ:CRON) are better equipped to withstand the COVID-19 storm.

So far this year, OrganiGram Holdings (NASDAQ:OGI) and Aphria (NYSE:APHA) have lost 11.0% and 36.7% of their stock price.

As the markets start to rebound, three cannabis stocks could deliver strong returns. Cannabis sales have increased amid the coronavirus outbreak.

On Tuesday, Curaleaf (OTCMKTS:CURLF) reported its fourth-quarter earnings after the market closed. The company reported revenue of $75.46 million.

On Monday, OrganiGram Holdings (NASDAQ:OGI) announced that it received a license from Health Canada to expand its Phase 5.

Last week was the worst week since October 2008. However, the cannabis sector fared better than the broader equity markets.

Curaleaf Holdings (OTCMKTS:CURLF) will report its fourth-quarter earnings after the market closes on March 24. Analysts are bullish on Curaleaf.

On March 19, Bank of America upgraded Aphria (NYSE:APHA) and OrganiGram Holdings (NASDAQ:OGI) due to the increased demand for cannabis.

Charlotte’s Web Holdings (NYSEARCA:CWEB) will report its earnings for the fourth quarter of 2019 before the market opens on March 24.

On March 16, Roth Capital initiated coverage on Innovative Industrial Properties (NYSE:IIPR) with a “buy” rating and a stock price of $110.

The marijuana sector saw a sharp decline last week amid the global sell-off. The S&P 500 fell by 8.8% in the week ending on March 13.

As of Thursday, nine analysts covered Curaleaf. Among the analysts, eight recommend a “buy,” while one recommends a “hold.”

On Thursday, WBRC reported that the Alabama Senate cleared Senate Bill 165. The bill will create the Compassion Act, which legalizes medical marijuana.

As of March 11, Innovative Industrial Properties (NYSE:IIPR) was trading at $76.96—a rise of 1.4% since the beginning of this year.

On Tuesday, MarketWatch reported that Stifel initiated its coverage on Aphria and HEXO. Stifel gave Aphria a “hold” and HEXO a “sell” rating.

Yesterday, Canopy Growth (NYSE:CGC)(TSE:WEED) announced that it’s optimizing its operations to align its supply based on demand.

On Wednesday, Charlotte’s Web Holdings (NYSEARCA:CWEB) announced that the audit of its 2019 hemp harvest is complete.

On Monday, Curaleaf (OTCMKTS:CURLF) announced that it will acquire BlueKudu—a company that produces premium cannabis chocolates and gummies.

As of February 28, Canopy Growth (NYSE:CGC)(TSE:WEED) was trading at 25.17 Canadian dollars. So far, the company has lost 7.8% of its stock value YTD.

On Monday, MarketWatch reported that Cowen downgraded Aurora Cannabis from “outperform” to “market perform” and lowered the target price.

The Senate Judiciary Committee of Alabama cleared the bill that legalizes medical marijuana in the state. The committee voted 8-1 in favor of the proposed legislation.

Green Growth Brands will likely report its results for the second quarter of fiscal 2020 on February 24. Analysts expect the company’s revenue to rise sequentially.

Kentucky’s House Judiciary Committee cleared House Bill 136, which legalizes medical marijuana. The committee cleared the bill in favor of a 17-1 vote.

On Friday, Canopy Growth will report its third-quarter earnings before the market opens. Investors will be watching the results closely.

Ontario’s government started collecting input from the public about allowing marijuana consumption in lounges and cafes across the province.

More Kentucky residents favor marijuana legalization. According to a poll, 90% of the respondents favor medical marijuana compared to 78% in 2012.

The Chicago Tribune reported that customers spent $39.2 million on recreational cannabis in Illinois the first month after legalization.

On Monday, Aurora Cannabis announced that its Aurora River production facility received EU GMP certification. The facility is located in Bradford, Ontario.

Canada legalized recreational cannabis on October 17, 2018. However, cannabis hasn’t met the government’s expected revenue collection.

Farmers expected high earnings from hemp cultivation. However, hemp prices have fallen. Farmers are struggling to find enough buyers.

On January 23, Statistics Canada announced that the average price of marijuana increased in the fourth quarter. The illegal marijuana price also increased.

On Thursday, Cresco Labs announced that it signed an agreement for a senior secured term loan for an initial aggregate principal amount of $100 million.

Yesterday, Aphria announced that it received GMP (Good Manufacturing Practices) certification from the EU for its subsidiary Avanti Rx Analytics.

Although 2019 was tough for Charlotte’s Web Holdings, it has made a significant recovery this year. The stock has increased by 14.8% YTD as of Monday.

Cowen reiterated its “buy” rating for Aurora Cannabis (NYSE:ACB). The investment firm maintained its target price of 6 Canadian dollars.

For CBD products, federal regulation could take years. However, the situation might change with the introduction of Collin Peterson’s new bill.

As of Wednesday, Aphria (NYSE:APHA) was trading at a forward EV-to-sales multiple of 2.38x. The valuation multiple increased despite the lower stock price.

Acquisitions could boost Curaleaf’s production and retail footprint significantly. With the EBITDA expected to rise over the next two years, there’s significant upside.

Many people expected the Cannabis 2.0 products, including cannabis edibles, to hit the markets by mid-December 2019. However, the products got delayed.

On January 10, HEXO was trading at 1.74 Canadian dollars, a fall of 63.1% since the beginning of 2019 and a discount of 84.6% to its 52-week high.

On January 12, GW Pharmaceuticals announced its preliminary unaudited product sales report for the fourth quarter and 2019.

KushCo Holdings reported its Q1 earnings on January 8. KushCo reported revenue of $34.96 million, below analysts’ forecast of $41.5 million.

Yesterday, MarketWatch reported that Piper Sandler had downgraded its rating for Aurora Cannabis (NYSE:ACB) to “sell” from “hold.”

While cannabis investors lost a lot of wealth last year, one stock continued to deliver staggering returns—Innovative Industrial Properties (IIPR).

Boosted by a strong broader US equity market, the cannabis sector was trading in the green today. Here are the cannabis stocks making big moves.

In June 2019, Illinois legalized adult-use cannabis, becoming the 11th state to do so. It was the first state to legalize marijuana through the legislature.

Yesterday, OrganiGram stock was trading at 2.68 Canadian dollars, 23.4% lower than when the company reported its fourth-quarter earnings on November 25.

Weakness in cannabis stocks continued today, the fourth day of decline. The US equity market fell today due to the growing tension between the US and Iran.

Analysts expect GW Pharmaceuticals to become profitable in 2020. They expect the company’s EBITDA to be $42.8 million in 2020.

The downward momentum in cannabis stocks has continued today, marking the third straight day of decline for the cannabis sector.

Democratic nominee Joe Biden thinks e-cigarette sales should only be allowed after scientific analysis of the products’ long-term impact on health.

On the back of the weakness in the broader equity market, the cannabis sector traded in the red today. At 1:28 PM ET, the S&P 500 Index was down by 0.4%.

TerrAscend’s recent private placement was oversubscribed due to strong investor interest. It increased the offering to about $30 million from $20 million.